These results not only imply a potential regulatory mechanism of FNDC5 to offset a high-fat diet-induced weight gain by increasing energy expenditure but also show the potential to be used as a therapeutic regimen for preventing inflammation and insulin resistance in obesity and diabetes. The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.